This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Drew C Deniger: Innovator in Immunotherapy
Introduction
Drew C Deniger is a prominent inventor based in Germantown, MD (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on polyclonal gamma delta T cells. His research focuses on expanding clinically-relevant quantities of these T cells, which have shown promise in targeting various tumors and infections.
Latest Patents
Drew C Deniger holds a patent for "Polyclonal gamma delta T cells for immunotherapy." This patent outlines a method for expanding polyclonal γδ T cells that exhibit anti-tumor, anti-viral, and anti-bacterial reactivity. These T cells are capable of targeting a variety of tumors, including solid tumors, as well as addressing other conditions such as viral and bacterial infections. He has 1 patent to his name.
Career Highlights
Drew is affiliated with the University of Texas System, where he continues to advance his research in immunotherapy. His work has the potential to revolutionize treatment options for patients suffering from various malignancies and infections.
Collaborations
Drew collaborates with Laurence J N Cooper, who is also involved in the field of immunotherapy. Their combined expertise contributes to the advancement of innovative therapeutic strategies.
Conclusion
Drew C Deniger is a key figure in the development of immunotherapy, with a focus on polyclonal gamma delta T cells. His contributions are paving the way for new treatment modalities that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile